Amdocs Short Long Term Debt Total vs Total Liab Analysis

DOX Stock

USD 79.91 1.06 1.31%

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs is a good investment. Please check the relationship between Amdocs Short Long Term Debt Total and its Total Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Short Long Term Debt Total vs Total Liab

Short Long Term Debt Total vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Short Long Term Debt Total account and Total Liab. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Amdocs' Short Long Term Debt Total and Total Liab is 0.57. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Total Liab in the same time period over historical financial statements of Amdocs, assuming nothing else is changed. The correlation between historical values of Amdocs' Short Long Term Debt Total and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Amdocs are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Short Long Term Debt Total i.e., Amdocs' Short Long Term Debt Total and Total Liab go up and down completely randomly.

Correlation Coefficient

0.57

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Short Long Term Debt Total

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 14.45 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	1.6B	1.7B	2.0B	1.1B
Total Revenue	4.6B	4.9B	5.6B	3.1B

Gross Profit Total Revenue

Amdocs fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock	Current Deferred Revenue	Other Liab
Total Assets		0.56	0.51	0.95	0.96	0.65	0.2	0.77	0.15	0.43	0.97	0.75	0.44	0.93	-0.88	0.65	0.73	-0.61	0.94	0.81	0.04	0.95	0.64	0.94	0.53	0.95
Short Long Term Debt Total	0.56		0.5	0.44	0.49	0.73	0.53	0.76	-0.05	-0.22	0.68	0.67	-0.25	0.67	-0.76	0.61	0.85	-0.77	0.57	0.15	0.11	0.62	0.73	0.63	0.09	0.47
Other Current Liab	0.51	0.5		0.37	0.32	0.85	0.79	0.78	-0.31	-0.05	0.59	0.77	0.03	0.37	-0.71	0.86	0.71	-0.83	0.67	0.19	-0.34	0.51	0.85	0.56	0.56	0.51
Total Current Liabilities	0.95	0.44	0.37		0.97	0.48	-0.01	0.69	0.32	0.48	0.88	0.65	0.52	0.92	-0.77	0.47	0.65	-0.46	0.82	0.86	0.13	0.94	0.47	0.92	0.47	0.87
Total Stockholder Equity	0.96	0.49	0.32	0.97		0.46	-0.06	0.67	0.35	0.54	0.87	0.65	0.55	0.93	-0.75	0.45	0.66	-0.41	0.8	0.89	0.23	0.92	0.45	0.9	0.38	0.86
Property Plant And Equipment Net	0.65	0.73	0.85	0.48	0.46		0.82	0.93	-0.35	-0.02	0.74	0.9	0.0	0.55	-0.86	0.98	0.87	-0.95	0.79	0.28	-0.32	0.66	1.0	0.7	0.57	0.67
Net Debt	0.2	0.53	0.79	-0.01	-0.06	0.82		0.6	-0.62	-0.47	0.39	0.57	-0.45	0.13	-0.58	0.79	0.53	-0.84	0.48	-0.28	-0.52	0.2	0.82	0.26	0.41	0.3
Retained Earnings	0.77	0.76	0.78	0.69	0.67	0.93	0.6		-0.13	0.1	0.81	0.95	0.16	0.72	-0.9	0.89	0.95	-0.9	0.81	0.49	-0.12	0.82	0.93	0.85	0.54	0.75
Accounts Payable	0.15	-0.05	-0.31	0.32	0.35	-0.35	-0.62	-0.13		0.5	0.0	-0.15	0.47	0.19	0.16	-0.34	-0.01	0.41	-0.08	0.44	0.11	0.17	-0.35	0.11	-0.35	-0.06
Cash	0.43	-0.22	-0.05	0.48	0.54	-0.02	-0.47	0.1	0.5		0.2	0.17	0.96	0.21	-0.03	0.1	0.06	0.24	0.27	0.84	0.14	0.33	-0.03	0.3	0.21	0.31
Non Current Assets Total	0.97	0.68	0.59	0.88	0.87	0.74	0.39	0.81	0.0	0.2		0.76	0.2	0.93	-0.96	0.71	0.77	-0.74	0.97	0.63	-0.01	0.93	0.73	0.93	0.51	0.94
Non Currrent Assets Other	0.75	0.67	0.77	0.65	0.65	0.9	0.57	0.95	-0.15	0.17	0.76		0.25	0.66	-0.83	0.9	0.91	-0.82	0.79	0.52	-0.19	0.78	0.9	0.81	0.56	0.77
Cash And Short Term Investments	0.44	-0.25	0.03	0.52	0.55	0.0	-0.45	0.16	0.47	0.96	0.2	0.25		0.22	-0.05	0.13	0.1	0.19	0.29	0.87	0.05	0.37	-0.01	0.34	0.34	0.37
Net Receivables	0.93	0.67	0.37	0.92	0.93	0.55	0.13	0.72	0.19	0.21	0.93	0.66	0.22		-0.87	0.49	0.74	-0.58	0.83	0.67	0.23	0.93	0.54	0.92	0.34	0.86
Common Stock Shares Outstanding	-0.88	-0.76	-0.71	-0.77	-0.75	-0.86	-0.58	-0.9	0.16	-0.03	-0.96	-0.83	-0.05	-0.87		-0.81	-0.84	0.89	-0.94	-0.48	0.06	-0.89	-0.85	-0.91	-0.53	-0.88
Non Current Liabilities Total	0.65	0.61	0.86	0.47	0.45	0.98	0.79	0.89	-0.34	0.1	0.71	0.9	0.13	0.49	-0.81		0.8	-0.89	0.81	0.34	-0.4	0.63	0.98	0.67	0.64	0.69
Other Current Assets	0.73	0.85	0.71	0.65	0.66	0.87	0.53	0.95	-0.01	0.06	0.77	0.91	0.1	0.74	-0.84	0.8		-0.83	0.72	0.44	-0.05	0.78	0.86	0.8	0.4	0.65
Other Stockholder Equity	-0.61	-0.77	-0.83	-0.46	-0.41	-0.95	-0.84	-0.9	0.41	0.24	-0.74	-0.82	0.19	-0.58	0.89	-0.89	-0.83		-0.76	-0.14	0.25	-0.62	-0.95	-0.67	-0.53	-0.64
Total Liab	0.94	0.57	0.67	0.82	0.8	0.79	0.48	0.81	-0.08	0.27	0.97	0.79	0.29	0.83	-0.94	0.81	0.72	-0.76		0.64	-0.18	0.88	0.79	0.89	0.64	0.95
Total Current Assets	0.81	0.15	0.19	0.86	0.89	0.28	-0.28	0.49	0.44	0.84	0.63	0.52	0.87	0.67	-0.48	0.34	0.44	-0.14	0.64		0.15	0.75	0.26	0.72	0.43	0.72
Short Term Debt	0.04	0.11	-0.34	0.13	0.23	-0.32	-0.52	-0.12	0.11	0.14	-0.01	-0.19	0.05	0.23	0.06	-0.4	-0.05	0.25	-0.18	0.15		0.09	-0.32	0.05	-0.41	-0.09
Common Stock Total Equity	0.95	0.62	0.51	0.94	0.92	0.66	0.2	0.82	0.17	0.33	0.93	0.78	0.37	0.93	-0.89	0.63	0.78	-0.62	0.88	0.75	0.09		0.65	1.0	0.44	0.89
Property Plant And Equipment Gross	0.64	0.73	0.85	0.47	0.45	1.0	0.82	0.93	-0.35	-0.03	0.73	0.9	-0.01	0.54	-0.85	0.98	0.86	-0.95	0.79	0.26	-0.32	0.65		0.69	0.57	0.67
Common Stock	0.94	0.63	0.56	0.92	0.9	0.7	0.26	0.85	0.11	0.3	0.93	0.81	0.34	0.92	-0.91	0.67	0.8	-0.67	0.89	0.72	0.05	1.0	0.69		0.47	0.91
Current Deferred Revenue	0.53	0.09	0.56	0.47	0.38	0.57	0.41	0.54	-0.35	0.21	0.51	0.56	0.34	0.34	-0.53	0.64	0.4	-0.53	0.64	0.43	-0.41	0.44	0.57	0.47		0.63
Other Liab	0.95	0.47	0.51	0.87	0.86	0.67	0.3	0.75	-0.06	0.31	0.94	0.77	0.37	0.86	-0.88	0.69	0.65	-0.64	0.95	0.72	-0.09	0.89	0.67	0.91	0.63

Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Other Current Liab	794.4M	886.6M	821.3M	849.4M	976.9M	1.0B
Total Current Liabilities	1.2B	1.3B	1.3B	1.4B	1.6B	1.0B
Total Stockholder Equity	3.6B	3.6B	3.5B	3.5B	4.1B	2.8B
Property Plant And Equipment Net	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Net Debt	50.0M	172.1M	253.5M	287.2M	258.5M	271.4M
Retained Earnings	5.3B	5.9B	6.2B	6.5B	7.5B	7.9B
Accounts Payable	930.3M	121.2M	134.4M	293.3M	337.3M	428.4M
Cash	983.2M	709.1M	573.4M	520.1M	598.1M	720.1M
Non Current Assets Total	4.3B	4.4B	4.4B	4.5B	5.2B	2.6B
Non Currrent Assets Other	488.6M	630.7M	574.9M	631.6M	726.3M	762.6M
Cash And Short Term Investments	983.9M	965.6M	818.0M	742.5M	853.9M	1.0B
Net Receivables	861.0M	866.8M	946.8M	944.5M	1.1B	618.6M
Common Stock Shares Outstanding	133.2M	128.0M	121.9M	118.5M	106.6M	144.3M
Liabilities And Stockholders Equity	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Non Current Liabilities Total	1.5B	1.6B	1.6B	1.5B	1.7B	1.8B
Other Current Assets	229.6M	235.1M	238.4M	224.6M	258.3M	307.0M
Other Stockholder Equity	(1.7B)	(2.3B)	(2.6B)	(3.0B)	(2.7B)	(2.5B)
Total Liab	2.7B	2.9B	2.8B	2.9B	3.3B	1.7B
Total Current Assets	2.1B	2.1B	2.0B	1.9B	2.2B	1.9B
Short Term Debt	159.1M	58.7M	43.3M	40.0M	46.0M	43.7M
Property Plant And Equipment Gross	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Accumulated Other Comprehensive Income	11.7M	9.3M	(72.5M)	(53.3M)	(47.9M)	(45.5M)
Common Stock	4.5M	4.5M	4.5M	4.6M	5.3M	4.4M
Current Deferred Revenue	126.8M	237.4M	253.7M	170.6M	196.2M	184.3M
Other Liab	542.4M	586.2M	750.3M	793.9M	913.0M	469.4M
Other Assets	423.9M	488.6M	630.7M	574.9M	661.2M	386.6M
Good Will	2.6B	2.6B	2.7B	2.7B	3.2B	1.9B
Intangible Assets	296.3M	259.0M	178.3M	181.5M	163.4M	317.6M
Property Plant Equipment	354.0M	723.6M	931.9M	971.2M	1.1B	1.2B
Short Term Investments	752K	256.5M	244.6M	222.5M	200.2M	266.3M
Net Tangible Assets	660.6M	567.8M	711.0M	676.6M	609.0M	676.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

DD	Dupont De Nemours
GM	General Motors
BAC	Bank of America

When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:

How To Invest In Amdocs

Details

Is Amdocs Stock a good investment?

Details

What is Amdocs' Net Worth?

Details

Largest Software - Infrastructure Companies

View

Largest Information Technology Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.18)

Dividend Share

1.784

Earnings Share

4.46

Revenue Per Share

42.22

Quarterly Revenue Growth

0.018

The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amdocs Short Long Term Debt Total vs Total Liab Analysis

Short Long Term Debt Total vs Total Liab

Short Long Term Debt Total vs Total Liab Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Total Liab

Amdocs fundamental ratios Correlations

Amdocs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amdocs fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Amdocs Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Liabilities Total	+ 0.98	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.98	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.97	Total Current Liabilities

Common Stock Shares Outstanding	- 0.96	Non Current Assets Total
Property Plant And Equipment Gross	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Property Plant And Equipment Net
Total Liab	- 0.94	Common Stock Shares Outstanding
Common Stock	- 0.91	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.9	Retained Earnings